Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Zenas BioPharma (ZBIO) Tax Provisions (2025)

Zenas BioPharma has reported Tax Provisions over the past 1 years, most recently at $106000.0 for Q4 2025.

  • Quarterly results put Tax Provisions at $106000.0 for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was -$79000.0 (changed N/A YoY), and the annual figure for FY2025 was -$79000.0, down 118.41%.
  • Tax Provisions for Q4 2025 was $106000.0 at Zenas BioPharma, up from $20000.0 in the prior quarter.
  • Over the last five years, Tax Provisions for ZBIO hit a ceiling of $106000.0 in Q4 2025 and a floor of -$205000.0 in Q1 2025.